Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Continuous Subcutaneous Insulin Infusion in Children: A Pilot Study Validating a Protocol to Avoid Hypoglycemia at Initiation.

Manousaki D, Deladoëy J, Geoffroy L, Olivier P.

Front Endocrinol (Lausanne). 2017 Apr 24;8:84. doi: 10.3389/fendo.2017.00084. eCollection 2017.

2.

Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.

Moreno-Fernandez J, Gómez FJ, Gálvez Moreno MÁ, Castaño JP.

J Diabetes Res. 2016;2016:4171789. doi: 10.1155/2016/4171789. Epub 2016 Nov 29.

3.

Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress.

Naranjo D, Tanenbaum ML, Iturralde E, Hood KK.

J Diabetes Sci Technol. 2016 Jun 28;10(4):852-8. doi: 10.1177/1932296816650900. Print 2016 Jul.

4.

Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience.

Hermansen K, Bohl M, Schioldan AG.

Drugs. 2016 Jan;76(1):41-74. doi: 10.1007/s40265-015-0500-0. Review.

5.

A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.

Majedah M. AbdulRasoul, Mousa M, Al-Mahdi M, Al-Sanaa H; Dalia Al-AbdulRazzaq, Al-Kandari H.

Oman Med J. 2015 Sep;30(5):336-43. doi: 10.5001/omj.2015.69.

6.

Insulin Pump Class: Back to the Basics of Pump Therapy.

Reece SW, Hamby Williams CL.

Diabetes Spectr. 2014 May;27(2):135-40. doi: 10.2337/diaspect.27.2.135. No abstract available.

7.

Efficacy of Insulin Pump Therapy on Diabetes Treatment Satisfaction and Glycemic Control Among Patients with Type 1 Diabetes Mellitus in Saudi Arabia: A Prospective Study.

Al Hayek AA, Robert AA, Al Dawish MA, Braham RB, Goudeh HS, Al Sabaan FS.

Diabetes Ther. 2015 Jun;6(2):227-36. doi: 10.1007/s13300-015-0107-1. Epub 2015 Apr 30.

8.

Study protocol for a randomised controlled trial of insulin delivery by continuous subcutaneous infusion compared to multiple daily injections.

Blair J, Gregory JW, Hughes D, Ridyard CH, Gamble C, McKay A, Didi M, Thornborough K, Bedson E, Awoyale L, Cwiklinski E, Peak M.

Trials. 2015 Apr 16;16:163. doi: 10.1186/s13063-015-0658-5.

9.

Basal insulin requirement of youth with type 1 diabetes differs according to age.

Urakami T, Kuwabara R, Habu M, Okuno M, Suzuki J, Takahashi S.

J Diabetes Investig. 2014 Jul;5(4):442-4. doi: 10.1111/jdi.12161. Epub 2013 Dec 2.

10.

Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years.

Wong JC, Dolan LM, Yang TT, Hood KK.

Pediatr Diabetes. 2015 Dec;16(8):592-9. doi: 10.1111/pedi.12221. Epub 2014 Nov 10.

11.

Evolving trends in insulin delivery in pursuit of improvements in diabetes management.

Akhrass F, Skinner N, Boswell K, Travis LB.

Am Health Drug Benefits. 2010 Mar;3(2):117-22.

12.

Continuous glucose monitoring in insulin-treated patients in non-ICU settings.

Gomez AM, Umpierrez GE.

J Diabetes Sci Technol. 2014 Sep;8(5):930-6. doi: 10.1177/1932296814546025. Epub 2014 Aug 13. Review.

13.

Consensus statement on diabetes in children.

Prasanna Kumar KM, Dev NP, Raman KV, Desai R, Prasadini TG, Das AK, Ramoul S.

Indian J Endocrinol Metab. 2014 May;18(3):264-73. doi: 10.4103/2230-8210.129714. Review.

14.

Factors associated with basal insulin dose in Japanese children and young adult type 1 diabetics.

Hashimoto T, Kawamura T, Kashihara Y, Hirose M, Higashide T, Tsuruhara A, Fujimoto H, Noi K, Shintaku H.

J Diabetes Investig. 2012 Jun 6;3(3):276-82. doi: 10.1111/j.2040-1124.2011.00171.x.

15.

The evidence base for diabetes technology: appropriate and inappropriate meta-analysis.

Pickup JC.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1567-74. Review.

16.

Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.

Leelarathna L, Little SA, Walkinshaw E, Tan HK, Lubina-Solomon A, Kumareswaran K, Lane AP, Chadwick T, Marshall SM, Speight J, Flanagan D, Heller SR, Shaw JA, Evans ML.

Diabetes Care. 2013 Dec;36(12):4063-70. doi: 10.2337/dc13-1004. Epub 2013 Oct 15.

17.

Improved quality of life in unselected insulin pump-treated children with type 1 diabetes in Eastern Nebraska.

Rendell S, Kosoko-Lasaki O, Penny G, Cook CT, Sharma A, Austin WP, Rendell M.

J Diabetes Sci Technol. 2013 Mar 1;7(2):579-81. No abstract available.

18.

Standards of medical care in diabetes--2013.

American Diabetes Association.

Diabetes Care. 2013 Jan;36 Suppl 1:S11-66. doi: 10.2337/dc13-S011. No abstract available.

19.

Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial).

Little S, Chadwick T, Choudhary P, Brennand C, Stickland J, Barendse S, Olateju T, Leelarathna L, Walkinshaw E, Tan HK, Marshall SM, Thomas RM, Heller S, Evans M, Kerr D, Flanagan D, Speight J, Shaw JA.

BMC Endocr Disord. 2012 Dec 13;12:33. doi: 10.1186/1472-6823-12-33.

20.

New technologies for diabetes: a review of the present and the future.

Ramchandani N, Heptulla RA.

Int J Pediatr Endocrinol. 2012 Oct 26;2012(1):28. doi: 10.1186/1687-9856-2012-28.

Supplemental Content

Support Center